3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Breast Neoplasms
7
Prostatic Neoplasms
5
Neoplasms
5
Multiple Myeloma
5
Depression
5
Sleep Initiation and Maintenance Disorders
4
Ovarian Neoplasms
4
Lung Neoplasms
4
Fatigue
4
Breast Carcinoma In Situ
4
Motor Activity
3
Leukemia
3
Uterine Cervical Neoplasms
2
Sleep Wake Disorders
2
Pancreatic Neoplasms
2
Pain
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Hodgkin Disease
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Anxiety Disorders
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Urinary Incontinence
1
Urinary Bladder Neoplasms
1
Torulopsis
1
Interventions
entinostat
3
Carboplatin
3
Pemetrexed
2
Bronchoscopy
2
sotorasib
1
pralsetinib
1
pembrolizumab
1
osimertinib
1
lorlatinib
1
ficlatuzumab
1
exemestane
1
demcizumab
1
cobimetinib
1
camrelizumab
1
aflibercept
1
Tyrosine Kinase Inhibitors
1
Thrombin
1
Temozolomide
1
TachoSil
1
Saline Solution
1
Radiomics
1
Paclitaxel
1
One-Lung Ventilation
1
Nutritional Status
1
Microscopy, Confocal
1
Gefitinib
1
Fibrinogen
1
Exercise
1
Erlotinib Hydrochloride
1
Diagnostic Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lung Diseases
×
Behavior Therapy
×
Clear all
NCT04630743
2020-11-16
CoBeMEB
University of Cologne
Phase NA
Completed
49 enrolled